Register / XX / DEA-XXX-2025-0007
World Health Organization · XX
DEA-XXX-2025-0007
Tier 1 · Regulator-publishedUnclassifiedMise en garde au publicStatus · active
- Issuing authority
- World Health Organization (WHO)
- Authority reference
- N°7/2025
- Date issued
- 15 Dec 2025
- Recorded by us
- 2026-09-07 21:22:20 UTC
- Produit
- IBRANCE (palbociclib)
- INN / active substance
- Not stated by the issuing authority
- Dosage form
- Not stated by the issuing authority
- Strength
- Not stated by the issuing authority
- Fabricant
- Not stated by the issuing authority
- Manufacturer country
- Not stated by the issuing authority
- MAH or importer
- Not stated by the issuing authority
- Numéros de lot
- Not published with the notice
- Dates de péremption
- Not published with the notice
- Action type
- Mise en garde au public
- Classification
- Not stated by the issuing authority
- Indicative severity
- Not assessed by Drug Eye Africa
- Defect category
- Falsifié
- Product type
- Médicament
- ATC code
- Not stated by the issuing authority
- Affected markets
- XX — no market beyond the issuing country was named on the notice
- Cross-border event
- Not linked to a cross-border event
- Texte de l’avis
- Not captured. The notice itself is linked below.
- Statut
- En vigueur
- Superseded by
- Not superseded. This is the current version.
- Version
- 11
Where this record came from, and what is held to show it.
- Primary source
- https://www.who.int/news/item/15-12-2025-medical-product-alert-n-7-2025--falsified-ibrance-(palbociclib)
- Copy of the source
- Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.Ask us for it and check it against the fingerprint below.
- Fingerprint
- 9fac231aa0739872608665695db0a7ee3bf561d71af9915386981b9baf5b8500SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
- Copy taken
- 2026-09-08 01:03:38 UTC
| Reference | Date | Country | Product | Batches | Action | Class | Source |
|---|---|---|---|---|---|---|---|
| DEA-XXX-2026-0003 | 03 Jul 2026 | XX | DARZALEX (daratumumab) | MYS7381 · STV1K01 | Public warning | Unclassified | Tier 1 · Regulator-published |
| DEA-EG-2026-0070 | Jul 2026 | EG | Tagrisso 80 mg film-coated tablets | FEST | Public warning | Unclassified | Tier 1 · Regulator-published |
| DEA-XXX-2026-0002 | 16 Jun 2026 | XX | JAKAVI (ruxolitinib) | none published | Public warning | Unclassified | Tier 1 · Regulator-published |
| DEA-EG-2026-0062 | Jun 2026 | EG | COLOVERIN-D 30 film Coated Tablets | 251035A | Public warning | Unclassified | Tier 1 · Regulator-published |
| DEA-EG-2026-0061 | Jun 2026 | EG | FLOPADEX 8mg Hard gelatin capsules 30 | 2504626 | Public warning | Unclassified | Tier 1 · Regulator-published |
| DEA-EG-2026-0060 | Jun 2026 | EG | Tears Guard Artificial Tears & Lubricant (Sterile Ophthalmic Solution) | 0425118 | Public warning | Unclassified | Tier 1 · Regulator-published |
Cite this record
Drug Eye Africa (2025). DEA-XXX-2025-0007: IBRANCE (palbociclib) — Mise en garde au public, World Health Organization. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/xx/2025/dea-xxx-2025-0007Version history
—No version history recorded for this record.
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.
Verification
Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.
Indexing
This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.